【结 构 式】 |
【分子编号】60994 【品名】N-[3-(1,2,3,6-tetrahydro-4-pyridinyl)phenyl]acetamide 【CA登记号】 |
【 分 子 式 】C13H16N2O 【 分 子 量 】216.28292 【元素组成】C 72.19% H 7.46% N 12.95% O 7.4% |
合成路线1
该中间体在本合成路线中的序号:(XI)N-Boc-4-Piperidone (VII) is converted into the enol triflate (VIII) upon treatment with N-phenyl trifluoromethanesulfonimide and LDA. Subsequent Suzuki coupling of (VIII) with 3-acetamidophenylboronic acid (IX) yields the 4-aryl tetrahydropyridine (X). Removal of the N-Boc group of (X) under acidic conditions furnishes the deprotected tetrahydropyridine (XI). Optionally, catalytic hydrogenation of (X) gives rise to piperidine (XII), which is then deprotected by acidic treatment to produce (XIII).
【1】 Gluchowski, C.; Chiu, G.; Marzabadi, M.R.; Nagarathnam, D.; Lagu, B.; Noble, S.; Wetzel, J.; Deleon, J.E. (Synaptic Pharmaceutical Corp.); Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof. EP 1299362; WO 0206245 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VII) | 18620 | tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone | 79099-07-3 | C10H17NO3 | 详情 | 详情 |
(VIII) | 32972 | tert-butyl 4-[[(trifluoromethyl)sulfonyl]oxy]-3,6-dihydro-1(2H)-pyridinecarboxylate | C11H16F3NO5S | 详情 | 详情 | |
(IX) | 60992 | 3-(acetylamino)phenylboronic acid | C8H10BNO3 | 详情 | 详情 | |
(X) | 60993 | tert-butyl 4-[3-(acetylamino)phenyl]-3,6-dihydro-1(2H)-pyridinecarboxylate | C18H24N2O3 | 详情 | 详情 | |
(XI) | 60994 | N-[3-(1,2,3,6-tetrahydro-4-pyridinyl)phenyl]acetamide | C13H16N2O | 详情 | 详情 | |
(XII) | 60995 | tert-butyl 4-[3-(acetylamino)phenyl]-1-piperidinecarboxylate | C18H26N2O3 | 详情 | 详情 | |
(XIII) | 60996 | N-[3-(4-piperidinyl)phenyl]acetamide | C13H18N2O | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(XI)Condensation of piperidine (XIII) with the N-bromopropyl derivative (VI) gives rise to the title compound. Alternatively, the title compound can be prepared by condensation of bromide (VI) with tetrahydropyridine (XI) to produce adduct (XIV), which is then hydrogenated over Pd/C.
【1】 Gluchowski, C.; Chiu, G.; Marzabadi, M.R.; Nagarathnam, D.; Lagu, B.; Noble, S.; Wetzel, J.; Deleon, J.E. (Synaptic Pharmaceutical Corp.); Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereof. EP 1299362; WO 0206245 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(VI) | 60991 | methyl (4S)-3-{[(3-bromopropyl)amino]carbonyl}-4-(3,4-difluorophenyl)-6-(methoxymethyl)-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxylate | C18H20BrF2N3O5 | 详情 | 详情 | |
(XI) | 60994 | N-[3-(1,2,3,6-tetrahydro-4-pyridinyl)phenyl]acetamide | C13H16N2O | 详情 | 详情 | |
(XIII) | 60996 | N-[3-(4-piperidinyl)phenyl]acetamide | C13H18N2O | 详情 | 详情 | |
(XIV) | 60997 | [1-(cyclopropylmethyl)-2-pyrrolidinyl]methanamine; [1-(cyclopropylmethyl)-2-pyrrolidinyl]methylamine | C31H35F2N5O6 | 详情 | 详情 |